All Stories

  1. Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study [Corrigendum]

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2014, Taylor & Francis

    Dr Vijay Kumar Thyagarajan Alagappan

  2. NVA237 einmal täglich bietet schnelle, klinisch bedeutsame und 24h anhaltende Bronchodilatation bei COPD-Patienten: die GLOW1 Studie

    Article • Pneumologie, February 2012, Thieme Publishing Group

    Dr Vijay Kumar Thyagarajan Alagappan

  3. Safety of formoterol in adults and children with asthma: a meta-analysis

    Article • Annals of Allergy Asthma & Immunology, July 2011, Elsevier

    Dr Vijay Kumar Thyagarajan Alagappan